<p>OMNI 360 Wealth Inc. 在最近向证券交易委员会的披露中表示，在第二季度将其在默克公司（NYSE:MRK - 免费报告）的股份增加了 252.2%。该机构投资者在此期间购买了额外的 6,772 股后，持有该公司 9,457 股股票。OMNI 360 Wealth Inc. 在默克公司的持股在最近的报告期末价值为 749,000 美元。</p>
<p>获取 <strong>默克公司</strong> 的提醒：</p>
<ul>
<li>随着市场轮动，这只医疗保健 ETF 引领潮流</li>
</ul>
<p>其他一些机构投资者和对冲基金也调整了对该公司的持股。Thurston Springer Miller Herd &amp; Titak Inc. 在第二季度将其在默克公司的股份增加了 24.3%。Thurston Springer Miller Herd &amp; Titak Inc. 目前持有 16,081 股该公司的股票，价值 1,273,000 美元，此前在上个季度购买了 3,141 股。Douglas Lane &amp; Associates LLC 在第二季度将其在默克公司的股份增加了 1.7%。Douglas Lane &amp; Associates LLC 目前持有 519,901 股该公司的股票，价值 41,155,000 美元，此前在上个季度购买了 8,486 股。McLean Asset Management Corp 在第二季度将其在默克公司的股份增加了 3.7%。McLean Asset Management Corp 目前持有 3,543 股该公司的股票，价值 292,000 美元，此前在上个季度增加了 125 股。Sage Capital Advisors LLC 在第二季度购买了默克公司的新股份，价值 4,042,000 美元。最后，Fiduciary Financial Group LLC 在第二季度将其在默克公司的股份增加了 7.7%。Fiduciary Financial Group LLC 目前持有 7,267 股该公司的股票，价值 595,000 美元，此前在上个季度增加了 521 股。76.07% 的股票由机构投资者持有。</p>
<h2>分析师升级和降级</h2>
<p>几位股票研究分析师最近对该股票发布了报告。摩根士丹利将默克公司的股票目标价从 99.00 美元下调至 98.00 美元，并在 7 月 10 日的研究报告中对该公司给予了 “持平” 评级。富国银行将默克公司的股票目标价从 97.00 美元下调至 90.00 美元，并在 7 月 30 日的报告中对该公司给予了 “持平” 评级。最后，Cantor Fitzgerald 在 5 月 20 日的报告中将默克公司的股票评级从 “增持” 下调至 “谨慎”。一位投资分析师对该股票给予了强烈买入评级，六位给予了买入评级，十二位给予了持有评级，一位给予了卖出评级。根据 MarketBeat.com 的数据，该股票目前的共识评级为 “持有”，平均目标价为 107.44 美元。</p>
<ul>
<li>Moderna 股票看起来适合短期挤压</li>
</ul>
<p><strong>阅读我们对默克公司的最新分析</strong></p>
<h2>默克公司股票表现</h2>
<p>MRK 股票在周五开盘价为 82.87 美元。该股票的市值为 2069.9 亿美元，市盈率为 12.77，市盈增长比率为 0.87，贝塔值为 0.37。该公司的债务与股本比率为 0.69，流动比率为 1.42，速动比率为 1.17。该公司的 50 日移动平均价格为 82.93 美元，200 日移动平均价格为 82.81 美元。默克公司的股票一年低点为 73.31 美元，一年高点为 119.38 美元。</p>
<ul>
<li>Moderna：首席执行官刚刚购买 500 万美元股票的 4 个关键原因</li>
</ul>
<p>默克公司（NYSE:MRK - 获取免费报告）最近在 7 月 29 日宣布了其季度收益结果。该公司报告季度每股收益为 2.13 美元，超出分析师共识预期的 2.03 美元，超出 0.10 美元。该公司在本季度的收入为 158.1 亿美元，而分析师预期为 159.2 亿美元。默克公司的净利润率为 25.79%，股本回报率为 41.05%。默克公司已将其 2025 财年的指导目标设定为每股收益 8.870-8.970 美元。作为一个整体，股票分析师预测默克公司在当前年度将发布每股收益 9.01 美元。</p>
<h2>默克公司宣布分红</h2>
<p>该公司最近还宣布了一项季度分红，将于 10 月 7 日（星期二）支付。9 月 15 日（星期一）的股东将获得 0.81 美元的分红。除息日为 9 月 15 日（星期一）。这代表着年化分红为 3.24 美元，收益率为 3.9%。默克公司的分红支付比率（DPR）目前为 49.92%。</p>
<h2>默克公司简介</h2>
<p>（免费报告）</p>
<p>默克公司是一家医疗保健公司，提供通过处方药、疫苗、生物治疗、动物健康和消费者护理产品的健康解决方案。它通过以下几个部门运营：制药、动物健康和其他。制药部门包括人类健康的制药和疫苗产品。</p>
<h2>进一步阅读</h2>
<ul>
<li>我们更喜欢的五只股票比默克公司更好</li>
<li>如何使用股票筛选器寻找股票</li>
<li>乘坐奢侈零售浪潮，投资这三只高端品牌股票</li>
<li>如何投资保险公司：指南</li>
<li>华尔街悄然大举押注这些中国科技巨头</li>
<li>3 只沃伦·巴菲特在波动时期必买的股票</li>
<li>Meta 的 6000 亿美元美国投资：对股票是看跌还是看涨？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1SSw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1SSw"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1000 美元在默克公司吗？</h2>
<p>在考虑默克公司之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其向客户推荐的股票。MarketBeat 已经识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而默克公司并不在名单上。</p>
<p>虽然默克公司目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

默克

<p>OMNI 360 Wealth Inc. 在第二季度将其在默克公司的股份增加了 252.2%，目前持有 9,457 股，价值 74.9 万美元。其他机构投资者也提高了他们的持股比例。分析师对默克的评级意见不一，普遍评级为 “持有”，平均目标价为 107.44 美元。默克的股票开盘价为 82.87 美元，市值为 2069.9 亿美元。该公司报告上个季度每股收益为 2.13 美元，超出预期，并宣布将于 10 月 7 日支付每股 0.81 美元的季度股息</p>

<p>OMNI 360 Wealth Inc. lifted its stake in shares of Merck &amp; Co., Inc. (NYSE:MRK - Free Report) by 252.2% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 9,457 shares of the company's stock after purchasing an additional 6,772 shares during the period. OMNI 360 Wealth Inc.'s holdings in Merck &amp; Co., Inc. were worth $749,000 at the end of the most recent reporting period.</p>
<div class="lb-trans"><p>OMNI 360 Wealth Inc. 在最近向证券交易委员会的披露中表示，在第二季度将其在默克公司（NYSE:MRK - 免费报告）的股份增加了 252.2%。该机构投资者在此期间购买了额外的 6,772 股后，持有该公司 9,457 股股票。OMNI 360 Wealth Inc. 在默克公司的持股在最近的报告期末价值为 749,000 美元。</p>
</div><p>Get <strong>Merck &amp; Co., Inc.</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>默克公司</strong> 的提醒：</p>
</div><ul>
<li>As the Market Rotates, This Healthcare ETF Is Leading the Way</li>
</ul>
<div class="lb-trans"><ul>
<li>随着市场轮动，这只医疗保健 ETF 引领潮流</li>
</ul>
</div><p>A number of other institutional investors and hedge funds have also modified their holdings of the business. Thurston Springer Miller Herd &amp; Titak Inc. raised its stake in shares of Merck &amp; Co., Inc. by 24.3% during the second quarter. Thurston Springer Miller Herd &amp; Titak Inc. now owns 16,081 shares of the company's stock worth $1,273,000 after buying an additional 3,141 shares during the last quarter. Douglas Lane &amp; Associates LLC increased its stake in Merck &amp; Co., Inc. by 1.7% in the second quarter. Douglas Lane &amp; Associates LLC now owns 519,901 shares of the company's stock valued at $41,155,000 after purchasing an additional 8,486 shares in the last quarter. McLean Asset Management Corp increased its position in shares of Merck &amp; Co., Inc. by 3.7% during the second quarter. McLean Asset Management Corp now owns 3,543 shares of the company's stock worth $292,000 after acquiring an additional 125 shares in the last quarter. Sage Capital Advisors llc bought a new stake in shares of Merck &amp; Co., Inc. during the second quarter worth $4,042,000. Finally, Fiduciary Financial Group LLC increased its position in shares of Merck &amp; Co., Inc. by 7.7% during the second quarter. Fiduciary Financial Group LLC now owns 7,267 shares of the company's stock worth $595,000 after acquiring an additional 521 shares in the last quarter. 76.07% of the stock is owned by institutional investors.</p>
<div class="lb-trans"><p>其他一些机构投资者和对冲基金也调整了对该公司的持股。Thurston Springer Miller Herd &amp; Titak Inc. 在第二季度将其在默克公司的股份增加了 24.3%。Thurston Springer Miller Herd &amp; Titak Inc. 目前持有 16,081 股该公司的股票，价值 1,273,000 美元，此前在上个季度购买了 3,141 股。Douglas Lane &amp; Associates LLC 在第二季度将其在默克公司的股份增加了 1.7%。Douglas Lane &amp; Associates LLC 目前持有 519,901 股该公司的股票，价值 41,155,000 美元，此前在上个季度购买了 8,486 股。McLean Asset Management Corp 在第二季度将其在默克公司的股份增加了 3.7%。McLean Asset Management Corp 目前持有 3,543 股该公司的股票，价值 292,000 美元，此前在上个季度增加了 125 股。Sage Capital Advisors LLC 在第二季度购买了默克公司的新股份，价值 4,042,000 美元。最后，Fiduciary Financial Group LLC 在第二季度将其在默克公司的股份增加了 7.7%。Fiduciary Financial Group LLC 目前持有 7,267 股该公司的股票，价值 595,000 美元，此前在上个季度增加了 521 股。76.07% 的股票由机构投资者持有。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师升级和降级</h2>
</div><p>Several equities research analysts have recently issued reports on the stock. Morgan Stanley lowered their price objective on shares of Merck &amp; Co., Inc. from $99.00 to $98.00 and set an &#34;equal weight&#34; rating for the company in a research report on Thursday, July 10th. Wells Fargo &amp; Company reduced their target price on shares of Merck &amp; Co., Inc. from $97.00 to $90.00 and set an &#34;equal weight&#34; rating for the company in a report on Wednesday, July 30th. Finally, Cantor Fitzgerald cut shares of Merck &amp; Co., Inc. from an &#34;overweight&#34; rating to a &#34;cautious&#34; rating in a report on Tuesday, May 20th. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, twelve have given a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of &#34;Hold&#34; and an average target price of $107.44.</p>
<div class="lb-trans"><p>几位股票研究分析师最近对该股票发布了报告。摩根士丹利将默克公司的股票目标价从 99.00 美元下调至 98.00 美元，并在 7 月 10 日的研究报告中对该公司给予了 “持平” 评级。富国银行将默克公司的股票目标价从 97.00 美元下调至 90.00 美元，并在 7 月 30 日的报告中对该公司给予了 “持平” 评级。最后，Cantor Fitzgerald 在 5 月 20 日的报告中将默克公司的股票评级从 “增持” 下调至 “谨慎”。一位投资分析师对该股票给予了强烈买入评级，六位给予了买入评级，十二位给予了持有评级，一位给予了卖出评级。根据 MarketBeat.com 的数据，该股票目前的共识评级为 “持有”，平均目标价为 107.44 美元。</p>
</div><ul>
<li>Moderna Stock Looks Ripe for a Short Squeeze</li>
</ul>
<div class="lb-trans"><ul>
<li>Moderna 股票看起来适合短期挤压</li>
</ul>
</div><p><strong>Read Our Latest Analysis on Merck &amp; Co., Inc.</strong></p>
<div class="lb-trans"><p><strong>阅读我们对默克公司的最新分析</strong></p>
</div><h2>Merck &amp; Co., Inc. Stock Performance</h2>
<div class="lb-trans"><h2>默克公司股票表现</h2>
</div><p>Shares of MRK stock opened at $82.87 on Friday. The stock has a market cap of $206.99 billion, a P/E ratio of 12.77, a P/E/G ratio of 0.87 and a beta of 0.37. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.42 and a quick ratio of 1.17. The company has a fifty day moving average price of $82.93 and a two-hundred day moving average price of $82.81. Merck &amp; Co., Inc. has a one year low of $73.31 and a one year high of $119.38.</p>
<div class="lb-trans"><p>MRK 股票在周五开盘价为 82.87 美元。该股票的市值为 2069.9 亿美元，市盈率为 12.77，市盈增长比率为 0.87，贝塔值为 0.37。该公司的债务与股本比率为 0.69，流动比率为 1.42，速动比率为 1.17。该公司的 50 日移动平均价格为 82.93 美元，200 日移动平均价格为 82.81 美元。默克公司的股票一年低点为 73.31 美元，一年高点为 119.38 美元。</p>
</div><ul>
<li>Moderna: 4 Key Reasons the CEO Just Bought $5M in Shares</li>
</ul>
<div class="lb-trans"><ul>
<li>Moderna：首席执行官刚刚购买 500 万美元股票的 4 个关键原因</li>
</ul>
</div><p>Merck &amp; Co., Inc. (NYSE:MRK - Get Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The company reported $2.13 EPS for the quarter, beating analysts' consensus estimates of $2.03 by $0.10. The firm had revenue of $15.81 billion during the quarter, compared to analysts' expectations of $15.92 billion. Merck &amp; Co., Inc. had a net margin of 25.79% and a return on equity of 41.05%. Merck &amp; Co., Inc. has set its FY 2025 guidance at 8.870-8.970 EPS. As a group, equities analysts predict that Merck &amp; Co., Inc. will post 9.01 EPS for the current year.</p>
<div class="lb-trans"><p>默克公司（NYSE:MRK - 获取免费报告）最近在 7 月 29 日宣布了其季度收益结果。该公司报告季度每股收益为 2.13 美元，超出分析师共识预期的 2.03 美元，超出 0.10 美元。该公司在本季度的收入为 158.1 亿美元，而分析师预期为 159.2 亿美元。默克公司的净利润率为 25.79%，股本回报率为 41.05%。默克公司已将其 2025 财年的指导目标设定为每股收益 8.870-8.970 美元。作为一个整体，股票分析师预测默克公司在当前年度将发布每股收益 9.01 美元。</p>
</div><h2>Merck &amp; Co., Inc. Announces Dividend</h2>
<div class="lb-trans"><h2>默克公司宣布分红</h2>
</div><p>The company also recently declared a quarterly dividend, which will be paid on Tuesday, October 7th. Shareholders of record on Monday, September 15th will be paid a $0.81 dividend. The ex-dividend date is Monday, September 15th. This represents a $3.24 dividend on an annualized basis and a yield of 3.9%. Merck &amp; Co., Inc.'s dividend payout ratio (DPR) is currently 49.92%.</p>
<div class="lb-trans"><p>该公司最近还宣布了一项季度分红，将于 10 月 7 日（星期二）支付。9 月 15 日（星期一）的股东将获得 0.81 美元的分红。除息日为 9 月 15 日（星期一）。这代表着年化分红为 3.24 美元，收益率为 3.9%。默克公司的分红支付比率（DPR）目前为 49.92%。</p>
</div><h2>Merck &amp; Co., Inc. Profile</h2>
<div class="lb-trans"><h2>默克公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Merck &amp; Co, Inc is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products.</p>
<div class="lb-trans"><p>默克公司是一家医疗保健公司，提供通过处方药、疫苗、生物治疗、动物健康和消费者护理产品的健康解决方案。它通过以下几个部门运营：制药、动物健康和其他。制药部门包括人类健康的制药和疫苗产品。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Merck &amp; Co., Inc.</li>
<li>How to Use Stock Screeners to Find Stocks</li>
<li>Ride the Luxury Retail Wave with These 3 High-End Brand Stocks</li>
<li>How to Invest in Insurance Companies: A Guide</li>
<li>Wall Street Quietly Bets Big on These Chinese Tech Giants</li>
<li>3 Must-Buy Warren Buffett Stocks for Volatile Times</li>
<li>Meta's $600B U.S. Investment: Bearish or Bullish for Shares?</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更喜欢的五只股票比默克公司更好</li>
<li>如何使用股票筛选器寻找股票</li>
<li>乘坐奢侈零售浪潮，投资这三只高端品牌股票</li>
<li>如何投资保险公司：指南</li>
<li>华尔街悄然大举押注这些中国科技巨头</li>
<li>3 只沃伦·巴菲特在波动时期必买的股票</li>
<li>Meta 的 6000 亿美元美国投资：对股票是看跌还是看涨？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1SSw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=MRK"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Merck &amp; Co., Inc. Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在默克公司吗？</h2>
</div><p>Before you consider Merck &amp; Co., Inc., you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑默克公司之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Merck &amp; Co., Inc. wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其向客户推荐的股票。MarketBeat 已经识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而默克公司并不在名单上。</p>
</div><p>While Merck &amp; Co., Inc. currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然默克公司目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

OMNI 360 Wealth Inc. 持有默克公司（Merck & Co., Inc.）价值 749,000 美元的股份